‘Investigating a vaccine’ study

This study aims to assess whether healthy people can be protected from COVID-19 with a new vaccine called ChAdOx1 nCoV-19 — providing information on the safety of the vaccine and its ability to generate good immune responses against SARS-CoV-2. The researchers will randomly allocate participants to receive the ChAdOx1 nCoV-19 vaccine or a MenACWY vaccine (that prevents meningitis and septicaemia) in addition to doing blood tests and collecting information about any symptoms that occur after vaccination.

Learn more on the ISRCTN registry